Crossmark

Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?

Crossref DOI link: https://doi.org/10.1007/s12325-022-02125-1

Published Online: 2022-03-28

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Papachristou, Stella

Popovic, Djordje S.

Papanas, Nikolaos https://orcid.org/0000-0002-7320-785X
License Information

Text and Data Mining valid from 2022-03-28

Version of Record valid from 2022-03-28
More Information

Article History

Received: 7 February 2022

Accepted: 10 March 2022

First Online: 28 March 2022

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below